FDA Approval Insights: Momelotinib in Myelofibrosis With Anemia
Season 9, Episode 34, Oct 16, 2023, 08:15 PM
Dr Kuykendall discusses the FDA approval of momelotinib in myelofibrosis with anemia, key data from the MOMENTUM trial, and how momelotinib alters the myelofibrosis treatment paradigm.